Research and development

Science & Research

ProLon’s state of the art research and development and pre-clinical and clinical trials were conducted at the University of Southern California’s Longevity Institute and Diabetes and Obesity Research Institute, and sponsored by the National Cancer Institutes (NCI) and National Institute on Aging (NIA) of the National Institute of Health(NIH).

The results of the above research were published in top scientific peer-reviewed journals.

White Papers

Cell Metabolism

July 7, 2015

A periodic diet that mimics fasting and promotes multi-system regeneration, enhanced cognitive performance, and health span.

Aging Cell

March 11, 2013

Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer’s disease mouse model.

Elsevier

February 21, 2013

Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.

PLOS ONE

September 11, 2012

Fasting enhances the response of glioma to chemo- anXd radiotherapy.X